TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Name / Ticker | Price | Zen Rating |
---|---|---|
$3.60 | A | |
$8.39 | A | |
$44.07 | A |